The Prognostic Value of Biomarkers and the Effect of Tolperisone in Acute Low Back Pain and Sciatic Pain "BETA"
Clinical trial NCT05544656 · UNKNOWN
Trial details
- NCT number
- NCT05544656
- Sponsor
- Semmelweis University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-13
- Primary completion
- 2023-12-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.